AU2002232061A1 - Compositions having improved bioavailability of eletriptan - Google Patents

Compositions having improved bioavailability of eletriptan

Info

Publication number
AU2002232061A1
AU2002232061A1 AU2002232061A AU2002232061A AU2002232061A1 AU 2002232061 A1 AU2002232061 A1 AU 2002232061A1 AU 2002232061 A AU2002232061 A AU 2002232061A AU 2002232061 A AU2002232061 A AU 2002232061A AU 2002232061 A1 AU2002232061 A1 AU 2002232061A1
Authority
AU
Australia
Prior art keywords
eletriptan
compositions
improved bioavailability
bioavailability
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002232061A
Inventor
Michael John Humphrey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of AU2002232061A1 publication Critical patent/AU2002232061A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2002232061A 2001-03-01 2002-02-20 Compositions having improved bioavailability of eletriptan Abandoned AU2002232061A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0105131.7 2001-03-01
GBGB0105131.7A GB0105131D0 (en) 2001-03-01 2001-03-01 Compositions having improved bioavailability
PCT/IB2002/000512 WO2002070070A2 (en) 2001-03-01 2002-02-20 Compositions having improved bioavailability of eletriptan

Publications (1)

Publication Number Publication Date
AU2002232061A1 true AU2002232061A1 (en) 2002-09-19

Family

ID=9909814

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002232061A Abandoned AU2002232061A1 (en) 2001-03-01 2002-02-20 Compositions having improved bioavailability of eletriptan

Country Status (8)

Country Link
EP (1) EP1372785A2 (en)
JP (1) JP2004529893A (en)
AU (1) AU2002232061A1 (en)
BR (1) BR0207751A (en)
CA (1) CA2439917A1 (en)
GB (1) GB0105131D0 (en)
MX (1) MXPA03007836A (en)
WO (1) WO2002070070A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089365A1 (en) * 2003-04-11 2004-10-21 Pfizer Limited Pharmaceutical combination comprising eletriptan and sodium bicarbonate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9709739D0 (en) * 1997-05-14 1997-07-02 Merck Sharp & Dohme Pharmaceutical formulation
US6255334B1 (en) * 1998-10-30 2001-07-03 Pfizer Inc 5HT 1 receptor agonists and metoclopramide for the treatment of migraine

Also Published As

Publication number Publication date
CA2439917A1 (en) 2002-09-12
GB0105131D0 (en) 2001-04-18
EP1372785A2 (en) 2004-01-02
MXPA03007836A (en) 2003-12-08
JP2004529893A (en) 2004-09-30
BR0207751A (en) 2004-03-09
WO2002070070A2 (en) 2002-09-12
WO2002070070A3 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
AU2002363005A1 (en) Derivatives of uk-2a
AU2002313236A1 (en) Medicinal compositions
AU2002349297A1 (en) Statin-like compounds
AU2002359165A1 (en) Novel compounds
AU2002361149A1 (en) Set of teeth
AU2002347377A1 (en) Sustained-release compositions
AU2002359026A1 (en) Compositon of dentifrice
AU2002365093A1 (en) Therapeutic compositions
AUPR600601A0 (en) Therapeutic compositions
AU2002341901A1 (en) Novel compositions of carvedilol
AU2002232061A1 (en) Compositions having improved bioavailability of eletriptan
AUPR920301A0 (en) Neurologically-active compounds
AU2002350154A1 (en) Preparation of polyethylene
AU2002346223A1 (en) Medicinal compositions
AU2002359898A1 (en) Preparation of alpha-diimines
AU2002338934A1 (en) Preparation of benzosuberonylpiperidine compounds
AU2002317699A1 (en) Improved synthesis of allofuranose
AU2002300773A1 (en) Preparation of Dialkylpyridylboranes
AU2002351839A1 (en) Solid oral compositions
AU2002320806A1 (en) Compositions
AUPR971001A0 (en) Compositions
AU2002302710A1 (en) Magnesium-enriched compositions
AU2002315611A1 (en) Fabric-cleaning compositions
AU2002338063A1 (en) Compositions for potentiating glutatthione
AU2004201666B2 (en) 4-Imidazolin-2-one compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase